Friday, August 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Banking & Insurance

Dow Jones Extends Monthly Winning Streak to Seven Sessions

Felix Baarz by Felix Baarz
November 29, 2025
in Banking & Insurance, Dow Jones, Industrial, Market Commentary, Value & Growth
0
Dow Jones Stock
0
SHARES
46
VIEWS
Share on FacebookShare on Twitter

The Dow Jones Industrial Average concluded November with an impressive seventh consecutive monthly advance, achieving a feat unmatched by either the Nasdaq or the S&P 500. A significant sector rotation is underway on Wall Street, where investors are shifting capital from former high-flying technology stocks toward traditional industrial, banking, and established tech companies. This strategic move raises questions about the underlying market dynamics.

Market Rotation in Full Swing

The driving force behind this shift appears to be growing market conviction. Traders are now pricing in an 87% probability of a Federal Reserve interest rate cut on December 10th, a substantial increase from the beginning of the month. This expectation is fueling a broad-based move out of highly-valued growth stocks and into cyclical and value-oriented equities.

The shortened Black Friday trading session highlighted this trend with surprising clarity. Intel emerged as the standout performer, with its shares skyrocketing 10.2% to lead the Dow Jones gainers. The chipmaker is benefiting from renewed optimism about a PC market recovery and its role in artificial intelligence integration, signaling that the tech resurgence is broadening beyond the typical market leaders.

In stark contrast, Nvidia, a previous AI favorite, declined 1.8% and finished November with a double-digit percentage loss. This performance suggests more than a minor correction; it indicates investor concern that valuations became overextended, prompting capital to flow toward value investments.

Should investors sell immediately? Or is it worth buying Dow Jones?

Financial heavyweights Goldman Sachs and JPMorgan Chase also contributed significantly to the index’s upward momentum. A steeper yield curve and robust economic data are creating favorable conditions for banking institutions. Meanwhile, in the pharmaceutical sector, Eli Lilly faced downward pressure, retreating 2.6%.

Commodities and Technical Strength Support Bullish Sentiment

Parallel developments in commodity markets further illustrate the current risk appetite. Silver broke through to a record high of $55.01, even outperforming Gold, which still posted a respectable 1.3% gain. Bitcoin maintained its position above $90,800, indicating that investor willingness to embrace risk assets persisted despite the holiday trading environment.

From a technical perspective, the Dow Jones demonstrates considerable strength. The index now sits just 1.12% below its all-time high of 48,254 points recorded on November 12th. Its V-shaped recovery over the past week points to substantial institutional buying activity. With the index trading comfortably above its key moving averages and the RSI indicating upward momentum without overbought conditions, the technical setup remains constructive.

The question facing market participants is no longer whether the Dow will reclaim its record high, but when that breakthrough will occur. The psychologically significant 48,000-point level represents the next major resistance barrier, which could potentially be overcome as early as December.

Ad

Dow Jones Stock: Buy or Sell?! New Dow Jones Analysis from August 7 delivers the answer:

The latest Dow Jones figures speak for themselves: Urgent action needed for Dow Jones investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 7.

Dow Jones: Buy or sell? Read more here...

Tags: Dow Jones
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

MSCI World ETF Stock
ETF

MSCI World ETF: Index Provider Rewrites the Rulebook for Fast-Moving Stocks

August 7, 2026
SK Hynix Stock
Asian Markets

SK Hynix’s Split Personality: Record Earnings, a Thin-Tape Glitch, and the $263 Billion Question

August 7, 2026
SpaceX Stock
IPOs

SpaceX Shares Rise as First Lock-Up Release Meets Strong Quarter

August 7, 2026
Next Post
Lockheed Stock

Lockheed Martin's Strategic Positioning: A Dual-Engine Growth Story

Palantir Stock

Palantir Shares Face Steep Decline Amid Valuation Concerns

Redcare Pharmacy Stock

Redcare Pharmacy Shares Show Signs of Recovery After Steep Decline

Recommended

Palantir Stock

Palantir Shares Face Valuation Pressures Despite Strong Earnings

9 months ago
BridgeBio Pharma Stock

BridgeBio Pharma Investors Await Critical Heart Drug Data

9 months ago
Ocugen Stock

Ocugen’s Fresh $130M Cushion Sets the Stage for a Data-Heavy July and a Pivotal Regulatory Filing

1 month ago
Airbnb Stock

Navigating Regulatory Headwinds and Innovation: Airbnb’s Strategic Crossroads

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

MSCI World ETF: Index Provider Rewrites the Rulebook for Fast-Moving Stocks

Airbus’ Paradox: A Slightly Smaller Forecast That Nobody Seems to Mind

Almonty Industries Rebounds From Index-Driven Exit as Tungsten Calculus Shifts Westward

OHB’s Two-Faced Half-Year: Record Orders Mask a Profit Squeeze That Spooked the Market

Trending

Nel ASA Stock
Analysis

Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding

by Jackson Burston
August 7, 2026
0

The Norwegian electrolyser maker Nel ASA is living a split-screen reality. Its order intake just exploded by...

SANDISK Stock

SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market

August 7, 2026
Bitcoin Stock

Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

August 7, 2026
Kioxia Stock

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

August 7, 2026
FALLBACK Stock

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

August 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding
  • SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market
  • Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com